Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841931 · ClinicalTrials.gov registry record · Phase 4
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
A Phase 4 study, sponsored by Theresa Jacob, PhD, MPH.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT01841931: Clinical Trial Phase 4 study, sponsored by Theresa Jacob, PhD, MPH.
NCT01841931 is a Phase 4 study that was terminated before completion, run by Theresa Jacob, PhD, MPH. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01841931, a Phase 4 study, was terminated before completion, sponsored by Theresa Jacob, PhD, MPH.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence of opioid withdrawal symptoms and improved quality of life.
Primary Outcome
Goal that patients will have NO withdrawal symptoms by the completion of their 3-day buprenorphine induction,and will remain withdrawal-free for the entire study duration. Assessed using Clinical Opiate Withdrawal Scale (COWS).
Interventions
- DRUG Buprenorphine/Naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Why NCT01841931 stopped before completion
NCT01841931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine/Naloxone is the first listed.
NCT01841931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01841931 about?
NCT01841931 is a clinical study titled "Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients". The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence...
What is the current status of trial NCT01841931?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2013-02. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01841931?
The interventions under investigation include: Buprenorphine/Naloxone (DRUG).
Who is sponsoring clinical trial NCT01841931?
This trial is sponsored by Theresa Jacob, PhD, MPH, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01841931's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia